CBD Synergies - SP+ References
- De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab. 2009; 23(1): 1-15. doi: https://doi.org/10.1016/j.beem.2008.10.013
- Pava MJ, et al. Endocannabinoid signaling regulates sleep stability. PLoS One. 2016; 11(3): e0152473. doi: https://doi.org/10.1371/journal.pone.0152473
- Murillo-Rodriguez E, et al. The endocannabinoid system may modulate sleep disorders in aging. Curr Neuropharmacol. 2020; 18(12): 97-108. doi: https://doi.org/10.2174/1570159×17666190801155922
- Pava ML, et al. Endocannabinoid modulation of cortical up-states and NREM sleep. PLoS One. 2014; 9(2): e88672. doi: https://doi.org/10.1371/journal.pone.0088672
- Kuhathasan N, et al. The use of cannabinoids for sleep: A critical review of clinical trials. Exp Clin Psychopharmacol. 2019; 27(4): 383-401. doi: https://doi.org/10.1037/pha0000285
- Linares IMP, Guimaraes FS, Eckeli A, et al. No acute effects of cannabidiol on the sleep-wake cycle of healthy subjects: A randomized, double-blind, placebo-controlled, crossover study. Front Pharmacol. 2018 ;9. doi: https://doi.org/10.3389/fphar.2018.00315
- Belendiuk KA, Babson KA, Vandrey R, Bonn-Miller MO. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addictive Behaviors. 2015;50:178-181. doi:https://doi.org/10.1016/j.addbeh.2015.06.032
- Calapai F, Cardia L, Esposito E, et al. Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives. Evid Based Complement Alternat Med: eCAM. 2022; 2022: 3336516. doi: https://doi.org/10.1155/2022/3336516
- Walsh JH, Maddison KJ, Rankin T, et al. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep. 2021; 44(11). doi: https://doi.org/10.1093/sleep/zsab149
- Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Daniele P, Shiromani PJ. Anandamide Enhances Extracellular Levels of Adenosine and Induces Sleep: An In Vivo Microdialysis Study. Sleep. 2003; 26(8): 943-947. doi: https://doi.org/10.1093/sleep/26.8.943
- Saper CB, et al. The hypothalamic integrator for circadian rhythms. Trends Neurosci. 2005; 28(3): 152-157. doi: https://doi.org/10.1016/j.tins.2004.12.009
- Costello RB, et al. The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J. 2014; 13: 106. doi: https://doi.org/10.1186/1475-2891-13-106
- Esposito S, et al. Pediatric sleep disturbances and treatment with melatonin. J Transl Med. 2019; 17: 77. doi: https://doi.org/10.1186/s12967-019-1835-1
- Vaughn LK, et al. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010; 160(3): 530-543. doi: https://doi.org/10.1111/j.1476-5381.2010.00790.x
- Oikonomou G, et al. The serotonergic raphe promote sleep in zebrafish and mice. Neuron. 2019; 103(4): 686-701. doi: https://doi.org/10.1016/j.neuron.2019.05.038
- Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998; 3(4): 271-280. https://altmedrev.com/wp-content/uploads/2019/02/v3-4-271.pdf
- Gant C. The role of 5 HTP as a precursor for serotonin and melatonin in the treatment of anxiety, panic disorder, sleep disorder, weight management, fibromyalgia, migraine and withdrawal from antidepressant medication. Semantic Scholar. Published 2004. https://www.semanticscholar.org/paper/The-Role-of-5-HTP-as-a-Precursor-for-Serotonin-and-Gant/13b8bb6db36e7453c83355f35a069713af84d4ba
- Takata Y, et al. Sleep and wakefulness are controlled by ventral medial midbrain/pons GABAergic neurons in mice. J Neurosci. 2018; 38(47): 10080-10092. doi: https://doi.org/10.1523/JNEUROSCI.0598-18.2018
- Yu X, et al. GABA and glutamate neurons in the VTA regulate sleep and wakefulness. Nature Neurosci. 2019; 22: 106-119. Doi: https://doi.org/10.1038/s41593-018-0288-9
- Plante DE, et al. The role of GABA in primary insomnia. Sleep. 2012; 35(6): 741-742. doi: https://doi.org/10.5665/sleep.1854
- Zhao T, et al. Scutellaria baicalensis Georgi. (Lamiaceae): a review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J Pharm Pharmacol. 2019; 71(9): 1353-1369. doi: https://doi.org/10.1111/jphp.13129
- Shia Y, et al. Herbal insomnia medications that target GABAergic systems: A review of the psychopharmacological evidence. Curr Neuropharmacol. 2014; 12(3): 289-302. doi: https://doi.org/10.2174/1570159X11666131227001243
- Elsas SM, et al. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010; 17(12): 940-949. doi: https://doi.org/10.1016/j.phymed.2010.03.002
- Guerrero FA, Medina GM. Effect of a medicinal plant (Passiflora incarnata L) on sleep. Sleep Sci. 2017; 10(3): 96-100. doi: https://doi.org/10.5935/1984-0063.20170018
- Toda K, et al. Passionflower extract induces high-amplitude rhythms without phase shifts in the expression of several circadian clock genes in vitro and in vivo. Int J Biomed Sci. 2017; 13(2): 84-92. https://pubmed.ncbi.nlm.nih.gov/28824345/
- Brown E, et al. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J. 2007; 75(5): 333-337. https://pubmed.ncbi.nlm.nih.gov/17966676/
